NUWE Nuwellis, Inc.
Price Chart
Executive Summary
Nuwellis reported mixed Q4 and full-year 2025 results: Q4 revenue rose 4% YoY to $2.4 million with strong gross margin expansion to 68.2%, but full-year revenue declined 5% to $8.3 million. The company incurred a $17.5 million net loss, driven by a $6.4 million non-cash warrant expense. It also announced a $5 million private placement, a new CFO, and an acquisition of Rendiatech to expand its cardiorenal portfolio.
Key Financial Metrics
Actionable Insight
Traders should monitor the integration of Rendiatech, progress on the Vivian pediatric solution, and whether Q4's commercial momentum sustains into 2026. The $5M capital raise provides near-term runway, but profitability remains a challenge.
Key Facts
- Q4 2025 revenue: $2.4 million, up 4% YoY and 9% sequentially
- Q4 gross margin improved to 68.2% from 58.4% in prior year
- Full-year 2025 revenue: $8.3 million, down 5% from 2024
- Net loss attributable to common shareholders: $17.5 million for the year
- Closed $5.0 million private placement in January 2026
- Appointed new CFO and announced acquisition of Rendiatech
Financial Impact
Revenue declined 5% for the year despite Q4 improvement; gross margin expanded significantly; $6.4M of the $17.5M net loss was non-cash warrant valuation
Risk Factors
- Full-year revenue declined despite Q4 improvement
- High net loss driven by recurring non-cash expenses and operating deficits
- Low cash balance of $1.2 million at year-end, though bolstered by $5M January raise
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3252779 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 22, 2026
1d ago
|
S-1
| — | awaiting T+5 | — | — |
|
May 12, 2026
11d ago
|
Press Release
| $1.03 $0.9800 | ▲ +4.85% | ▲ +4.93% | $1.05 (−1.94%) |
|
May 5, 2026
18d ago
|
Press Release
| $1.11 $1.04 | ▼ −6.31% | ▼ −8.29% | $1.05 (−5.41%) |
|
Apr 29, 2026
24d ago
|
Press Release
| $1.11 $1.11 | · 0.00% | ▼ −3.11% | $1.05 (−5.41%) |
|
Apr 24, 2026
29d ago
|
8-K
| $1.16 $1.12 | ▼ −3.45% | ▼ −3.85% | $1.05 (−9.48%) |
|
Mar 10, 2026
10w ago
|
Press Release
| $1.30 $1.08 | ▼ −16.92% | ▼ −16.02% | $1.05 (−19.23%) |
|
Feb 26, 2026
12w ago
|
8-K
| $1.60 $1.48 | ▼ −7.50% | ▼ −6.37% | $1.05 (−34.38%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access